{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T20:29:45Z","timestamp":1762547385303,"version":"build-2065373602"},"reference-count":33,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","trasci.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transfusion and Apheresis Science"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.transci.2025.104203","type":"journal-article","created":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T19:16:42Z","timestamp":1752607002000},"page":"104203","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Mitochondrial DNA levels in plasma products: A comparative study of apheresis plasma from COVID-19 convalescent donors and apheresis and fresh frozen plasma from non-infected donors"],"prefix":"10.1016","volume":"64","author":[{"given":"Fatemeh","family":"Tavangar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Azita","family":"Chegini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maryam","family":"Zadsar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shahram","family":"Samiee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.transci.2025.104203_bib1","first-page":"9S","article-title":"Plasma components: properties, differences, and uses","volume":"52","author":"Benjamin","year":"2012","journal-title":"Transfusion"},{"key":"10.1016\/j.transci.2025.104203_bib2","doi-asserted-by":"crossref","first-page":"9490","DOI":"10.1073\/pnas.2004168117","article-title":"Effectiveness of convalescent plasma therapy in severe COVID-19 patients","volume":"117","author":"Duan","year":"2020","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.transci.2025.104203_bib3","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1111\/trf.15910","article-title":"How did we rapidly implement a convalescent plasma program?","volume":"60","author":"Budhai","year":"2020","journal-title":"Transfusion"},{"key":"10.1016\/j.transci.2025.104203_bib4","series-title":"UpToDate","article-title":"COVID-19: convalescent plasma and hyperimmune globulin","author":"Bloch","year":"2021"},{"key":"10.1016\/j.transci.2025.104203_bib5","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2020-239762","article-title":"Convalescent plasma for COVID-19 complicated by ARDS due to TRALI","volume":"14","author":"Wang","year":"2021","journal-title":"BMJ Case Rep"},{"key":"10.1016\/j.transci.2025.104203_bib6","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.blre.2009.07.005","article-title":"Transfusion-related acute lung injury (TRALI): current concepts and misconceptions","volume":"23","author":"Silliman","year":"2009","journal-title":"Blood Rev"},{"key":"10.1016\/j.transci.2025.104203_bib7","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1182\/blood-2018-10-833988","article-title":"Noninfectious transfusion-associated adverse events and their mitigation strategies","volume":"133","author":"Goel","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.transci.2025.104203_bib8","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1159\/000345688","article-title":"Transfusion-related acute lung injury: the work of DAMPs","volume":"40","author":"Land","year":"2013","journal-title":"Transfus Med Hemother"},{"key":"10.1016\/j.transci.2025.104203_bib9","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1007\/s10495-021-01663-3","article-title":"Release mechanisms of major DAMPs","volume":"26","author":"Murao","year":"2021","journal-title":"Apoptosis"},{"key":"10.1016\/j.transci.2025.104203_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2021.102867","article-title":"Dysfunctional mitochondria as critical players in the inflammation of autoimmune diseases: potential role in Sj\u00f6gren\u2019s syndrome","volume":"20","author":"Barrera","year":"2021","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.transci.2025.104203_bib11","doi-asserted-by":"crossref","DOI":"10.4110\/in.2018.18.e27","article-title":"Damage-associated molecular patterns in inflammatory diseases","volume":"18","author":"Roh","year":"2018","journal-title":"Immune Netw"},{"key":"10.1016\/j.transci.2025.104203_bib12","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1016\/j.clinthera.2016.02.028","article-title":"Key role of DAMP in inflammation, cancer, and tissue repair","volume":"38","author":"Pandolfi","year":"2016","journal-title":"Clin Ther"},{"key":"10.1016\/j.transci.2025.104203_bib13","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1097\/SLA.0b013e3182a4ea46","article-title":"Elevated levels of plasma mitochondrial DNA DAMPs are linked to clinical outcome in severely injured human subjects","volume":"258","author":"Simmons","year":"2013","journal-title":"Ann Surg"},{"key":"10.1016\/j.transci.2025.104203_bib14","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1097\/TA.0000000000001421","article-title":"Potential contribution of mitochondrial DNA damage associated molecular patterns in transfusion products to the development of acute respiratory distress syndrome after multiple transfusions","volume":"82","author":"Simmons","year":"2017","journal-title":"J Trauma Acute Care Surg"},{"key":"10.1016\/j.transci.2025.104203_bib15","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1111\/vox.13794","article-title":"Investigating the impact of mitochondrial DNA: insights into blood transfusion reactions and mitigation strategies","volume":"120","author":"Bagheri","year":"2025","journal-title":"Vox Sang"},{"key":"10.1016\/j.transci.2025.104203_bib16","series-title":"Mitochondrial medicine: volume I, probing mitochondrial function","first-page":"117","article-title":"Accurate measurement of circulating mitochondrial DNA content from human blood samples using real-time quantitative PCR","author":"Ajaz","year":"2015"},{"key":"10.1016\/j.transci.2025.104203_bib17","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.3390\/diagnostics11091663","article-title":"Safety and efficacy of convalescent plasma in COVID-19: an overview of systematic reviews","volume":"11","author":"Franchini","year":"2021","journal-title":"Diagnostics"},{"key":"10.1016\/j.transci.2025.104203_bib18","doi-asserted-by":"crossref","first-page":"e00200","DOI":"10.1128\/cmr.00200-21","article-title":"COVID-19 convalescent plasma and clinical trials: understanding conflicting outcomes","volume":"35","author":"Focosi","year":"2022","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.transci.2025.104203_bib19","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.50647","article-title":"COVID-19 convalescent plasma for the treatment of immunocompromised patients: a systematic review and meta-analysis","volume":"6","author":"Senefeld","year":"2023","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.transci.2025.104203_bib20","first-page":"445","article-title":"Viable lymphocytes in fresh frozen plasma as a potential source of graft-versus-host disease: risks and solutions","volume":"19","author":"Brando","year":"2021","journal-title":"Blood Transfus"},{"key":"10.1016\/j.transci.2025.104203_bib21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1423-0410.2005.00648.x","article-title":"Transfusion-related acute lung injury (TRALI): a serious adverse event of blood transfusion","volume":"89","author":"Bux","year":"2005","journal-title":"Vox Sang"},{"key":"10.1016\/j.transci.2025.104203_bib22","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.jss.2014.06.003","article-title":"Blood transfusion products contain mitochondrial DNA damage-associated molecular patterns: a potential effector of transfusion-related acute lung injury","volume":"191","author":"Lee","year":"2014","journal-title":"J Surg Res"},{"key":"10.1016\/j.transci.2025.104203_bib23","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1046\/j.1537-2995.2003.00543.x","article-title":"Residual cell content in plasma produced by three centrifugal apheresis procedures","volume":"43","author":"Burnouf","year":"2003","journal-title":"Transfusion"},{"key":"10.1016\/j.transci.2025.104203_bib24","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0955-3886(00)00128-4","article-title":"Cellular contamination of plasma collected with various apheresis systems","volume":"24","author":"Valbonesi","year":"2001","journal-title":"Transfus Apher Sci"},{"key":"10.1016\/j.transci.2025.104203_bib25","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1111\/j.1537-2995.2004.03314.x","article-title":"Collection of white blood cell-reduced plasma by apheresis","volume":"44","author":"Vrielink","year":"2004","journal-title":"Transfusion"},{"key":"10.1016\/j.transci.2025.104203_bib26","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/vox.12390","article-title":"Manufacturing method affects mitochondrial DNA release and extracellular vesicle composition in stored red blood cells","volume":"111","author":"Bakkour","year":"2016","journal-title":"Vox Sang"},{"key":"10.1016\/j.transci.2025.104203_bib27","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1111\/trf.13535","article-title":"Mitochondrial damage-associated molecular patterns as potential proinflammatory mediators in post\u2013platelet transfusion adverse effects","volume":"56","author":"Yasui","year":"2016","journal-title":"Transfusion"},{"key":"10.1016\/j.transci.2025.104203_bib28","doi-asserted-by":"crossref","first-page":"7210","DOI":"10.1039\/D1MA00859E","article-title":"Blood apheresis technologies\u2013a critical review on challenges towards efficient blood separation and treatment","volume":"2","author":"Bacal","year":"2021","journal-title":"Mater Adv"},{"key":"10.1016\/j.transci.2025.104203_bib29","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1111\/1744-9987.13950","article-title":"Comparison mitochondrial DNA DAMPs changes in platelet prepared by apheresis and PRP","volume":"27","author":"Chegini","year":"2023","journal-title":"Ther Apher Dial"},{"key":"10.1016\/j.transci.2025.104203_bib30","article-title":"Circulating mitochondrial DNA is an early indicator of severe illness and mortality from COVID-19","volume":"6","author":"Scozzi","year":"2021","journal-title":"JCI Insight"},{"key":"10.1016\/j.transci.2025.104203_bib31","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2021.754708","article-title":"Peripheral blood mitochondrial DNA levels were modulated by SARS-CoV-2 infection severity and its lessening was associated with mortality among hospitalized patients with COVID-19","volume":"11","author":"Vald\u00e9s-Aguayo","year":"2021","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/j.transci.2025.104203_bib32","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0176795","article-title":"Selective mitochondrial DNA degradation following double-strand breaks","volume":"12","author":"Moretton","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.transci.2025.104203_bib33","doi-asserted-by":"crossref","first-page":"2382","DOI":"10.1161\/hs1001.097099","article-title":"Reduction and restoration of mitochondrial DNA content after focal cerebral ischemia\/reperfusion","volume":"32","author":"Chen","year":"2001","journal-title":"Stroke"}],"container-title":["Transfusion and Apheresis Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1473050225001417?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1473050225001417?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T20:25:01Z","timestamp":1762547101000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1473050225001417"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":33,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["S1473050225001417"],"URL":"https:\/\/doi.org\/10.1016\/j.transci.2025.104203","relation":{},"ISSN":["1473-0502"],"issn-type":[{"type":"print","value":"1473-0502"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mitochondrial DNA levels in plasma products: A comparative study of apheresis plasma from COVID-19 convalescent donors and apheresis and fresh frozen plasma from non-infected donors","name":"articletitle","label":"Article Title"},{"value":"Transfusion and Apheresis Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.transci.2025.104203","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"104203"}}